U.S. Confirms More Severe MPOX Strain as Europe Tracks New Hantavirus Cases

The Connecticut Department of Public Health said the infected individual had recently traveled to Western Europe, where health authorities have continued monitoring infectious disease activity tied to international travel and regional outbreaks. Officials emphasized that the case does not currently present a broader public health threat, though they continue to encourage vaccination among individuals considered at higher risk.

Mpox, formerly known as monkeypox, is a viral disease related to smallpox but generally less severe. Symptoms can include fever, fatigue, swollen lymph nodes, and a distinctive rash that may spread across the body. The Centers for Disease Control and Prevention continues to recommend the two-dose JYNNEOS vaccine for individuals at elevated risk of exposure.

Health officials say the distinction between clade I and clade II mpox remains important because the two forms of the virus differ significantly in severity and historical geographic spread. Clade I, historically found in Central Africa, has been associated with higher mortality rates and more serious complications. Clade II, which circulated primarily in West Africa, was responsible for the international outbreak that spread rapidly through Europe and North America beginning in 2022.

During the 2022 outbreak, thousands of cases were reported globally, including widespread transmission across the United States. Public health agencies responded with vaccination campaigns, public education efforts, and expanded testing capacity. Sonoma County and other California regions participated in vaccination outreach programs as health officials worked to contain transmission in high-risk populations and large public gatherings.

Although case numbers eventually declined, infectious disease experts have repeatedly warned that mpox had not been eliminated and could continue resurfacing through international travel or localized outbreaks. The emergence of clade I in the United States has renewed attention on monitoring efforts because the strain has historically produced more severe outcomes than the variant seen during the 2022 outbreak.

Meanwhile, European health agencies are also monitoring newly reported hantavirus cases in Spain and France. Hantavirus is a rare but potentially dangerous disease typically spread through exposure to infected rodents or contaminated materials. In severe cases, the illness can lead to hantavirus pulmonary syndrome, a life-threatening respiratory condition.

Hantavirus outbreaks have historically been uncommon in Europe and North America, though sporadic cases have occurred for decades. In the United States, hantavirus gained national attention in 1993 after a deadly outbreak in the Four Corners region of the Southwest, where a cluster of unexplained respiratory illnesses led scientists to identify the virus in deer mouse populations.

Public health officials say the current reports involving both mpox and hantavirus do not indicate widespread outbreaks, but they reflect how quickly infectious diseases can re-emerge in an interconnected world. Increased global travel, climate conditions affecting wildlife populations, and international public gatherings continue to challenge health agencies tasked with identifying and containing new health threats before they spread more broadly.

The CDC and WHO continue to advise travelers and healthcare providers to remain alert for symptoms associated with mpox and other emerging infectious diseases, particularly as summer travel and festival season increase opportunities for international movement and large gatherings.